Showing posts with label R&D. Show all posts
Showing posts with label R&D. Show all posts

Wednesday, November 19, 2014

China Li-ion Battery Market: enthusiastic government support for alternative energy vehicles is promising, but domestic manufacturers need to close the R&D gap

enthusiastic government support for alternative energy vehicles is promising

Boosted by enthusiastic policy support from both national and local government, China’s alternative energy vehicle market is booming. Production and sales have almost tripled year on year in 2014, and big increases are also predicted for 2015. The market’s fast growth is good news for China’s lithium-ion (Li-ion) battery industry, which should see its fortunes revived in 2015. However, CCM has warned that the gulf in R&D capabilities between domestic Chinese manufacturers and their international competitors could still do great harm to domestic companies’ long-term competitiveness.

Over the last few months, the Chinese government has demonstrated its determination to accelerate the development of the alternative energy market with a series of supportive policy announcements. In mid-July, the General Office of the State Council of the People's Republic of China (GOSC) implemented the Proposal on Purchasing Alternative Energy Automobiles for Governments and Public Institution, and GOSC followed this up in late-July by publishing the Guidance Concerning Accelerating Expansion and Application of Alternative Energy Automobiles. Among the proposals contained in the latter, the decisions not to restrict the entry of foreign alternative energy automobiles entering into local markets and to include charging stations in plans for local infrastructure were particularly noteworthy.

Then, in early August, China’s Ministry of Finance (MOF), the State Administration of Taxation, and the Ministry of Industry and Information Technology (MIIT) jointly issued the Announcement on Tax Exemption for Purchasing Alternative Energy Automobiles, announcing that vehicle purchase tax exemptions would come into force from September 1st 2014. At the end of August 2014, MIIT released the list of the first 113 vehicle models to be freed from vehicle purchase tax. This list comprised models from 25 enterprises, including Beijing Automobile Works Co., Ltd., Guangzhou Automobile Group Co., Ltd., Anhui Jianghuai Automobile Co., Ltd. and BYD Auto Co., Ltd.

Chinese consumers are already showing a strong interest in alternative energy automobiles. According to the China Association of Automobile Manufacturers, between January and September 2014 China produced 38,522 and sold 38,163 alternative energy automobiles, increases of 290% and 280% over the corresponding period in 2013 respectively. Moreover, in September 2014 domestic output of alternative energy automobiles reached 10,113, 11 times higher than the output in September 2013 and the first time monthly output had ever exceeded 10,000.

However, while the alternative energy vehicle market is sure to grow strongly in the years to come, the fate of China’s domestic alternative energy vehicle manufacturers and their upstream suppliers is far from certain. Both the government and the domestic companies themselves appear to be ignoring the basic reality that China’s R&D capabilities in this area lag far behind the industry leaders in the US, Japan, and Europe. This presents a huge long-term risk to China’s domestic alternative energy vehicle industry, and a corresponding opportunity to the international competition.

Indeed, it could be argued that current policy in China will directly benefit overseas manufacturers with superior technology. The recently-announced policies tend to favor market openness and subsidies for consumers, such as the subsidies from both national and local governments on purchasing alternative energy automobiles, the purchase tax exemption on alternative energy automobiles, and the growing list of cities expanding and applying alternative energy automobiles.

According to CCM’s research, the two most important factors that individual Chinese consumers (who make up the majority of the market) consider when purchasing an alternative energy automobile are cost-effectiveness and battery life, and currently Chinese companies lack the technological know-how to compete on these two aspects.

For instance, one of the core components in an alternative energy vehicle, the advanced brake system, must not only comprise an anti-skid brake system (ABS), electronic stability program (ESP) and other functions, but also achieve effective energy recovery. An efficient electric energy recovery system can effectively increase an automobile’s driving range by up to thirty per cent. Many Japanese, German and American enterprises have full-fledged technologies and products in this area and have achieved industrialization.

In China, on the other hand, industry experts have informed CCM that although some manufacturers have successfully coupled control between ABS and the motor brake, their system control technology and related industrialization are still at primary levels and the electric energy recovery of the on-sale alternative energy automobiles does not achieve satisfying results. Moreover, the coupled control between ESP and the motor system is still at the R&D and experiment stages.

Similarly, there are concerns over the development of power Li-ion battery technology in China. CCM has learned that although many alternative energy automobile companies have purchased Chinese-manufactured power Li-ion batteries, these deals tend mainly to be used merely as leverage to gain a better price when negotiating with foreign suppliers. Once this aim is achieved, these companies will not make any further purchases from the Chinese suppliers.

For this reason, few domestic power Li-ion battery manufacturers are developing their strengths, since they are failing to maintain long-term bulk orders. Besides, domestic manufacturers are not investing enough in R&D. More worringly, many strong overseas enterprises engaged in power Li-ion battery business have started to set up plants in China, as they are supported by preferential policies from some local governments. Thus, China’s power Li-ion battery industry will face increasingly intensified threats from overseas competitors.

It is predicted that during the Thirteenth Five-year Plan (2016-2020), China will continue issuing favorable policies promoting the alternative energy vehicle market. However, if the fact of domestic Chinese manufacturers’ technological inferiority is not addressed, the prospects for the long-term development of China’s alternative energy vehicle industry may not be so promising.

-          This article was provided by CCM, a leading provider of data and business intelligence on China’s chemicals market. CCM has launched China Li-ion Battery E-News, a new e-journal dedicated to analyzing all the latest news and trends in China’s Li-ion battery industry. For more information on CCM and China Li-ion Battery E-News, please visit www.cnchemicals.com or contact econtact@cnchemicals.com

-          Facebook: https://www.facebook.com/ccmkate

-          Twitter: https://twitter.com/CCM_Kcomber

Friday, November 14, 2014

Tinci makes decisive move to strengthen its Li-ion battery electrolyte business

Since late September, Chinese Guangzhou Tinci Materials Technology Co., Ltd. (Tinci) has taken several actions that indicate it is attempting to maneuver itself into the supply chain of Apple and BMW. According to independent China market research firm CCM, if Tinci is successful, it is possible it could establish itself as China’s leading supplier of Li-ion battery electrolyte.

The first signs that Tinci was making a move to strengthen its Li-ion battery electrolyte business came on September 23rd, when the company announced that it had completed a capital increase for its wholly-owned subsidiary Jiujiang Tinci Materials Technology Co., Ltd. (Jiujiang Tinci).

Jiujiang Tinci is mainly engaged in the R&D, production and operation of Li-ion battery electrolyte (6,000 t/a) and crystal lithium hexafluorophosphate (crystal LiPF6) (2,000 t/a). Through this capital increase, Jiujiang Tinci’s registered capital increased to USD32.52 million (RMB200 million) from USD16.26 million (RMB100 million).

A week later, on September 30th, Tinci de-listed another of its wholly-owned subsidiaries, Suichang Tinci Materials Technology Co., Ltd. (Suichang Tinci). Officials at Tinci stated that the decision to de-list Suichang Tinci was made in accordance with the company's overall strategy focusing on the Li-ion battery electrolyte business, and will help Tinci integrate and optimize its resource allocation, reduce costs in production and management, and improve its operating benefits.

Meanwhile, also on September 30th, it emerged that Tinci was planning to make a private offering to raise further funds.  According to the plan, Tinci will issue 8.18 million shares at most at approximately USD5.27 (RMB32.40) per share. In total, this offering should raise an extra USD43.09 million (RMB265 million).

CCM has learned that Tinci plans to use these funds to buy out Dongguan Kaixin Battery Material Co., Ltd. (Dongguan Kaixin) for no more than USD32.52 million (RMB200 million), and also USD7.97 million (RMB49 million) in the construction of a new 6,000 t/a liquid LiPF6 project. This move suggests a decisive pivoting of Tinci’s business towards the Li-ion battery electrolyte industry.

Moreover, according to CCM’s sources, Tinci is not only, or even primarily interested in acquiring Dongguan Kaixin to expand its Li-ion battery electrolyte business. Rather, Tinci is very keen to gain access to Dongguan Kaixin’s client base.

Competition in China’s Li-ion battery electrolyte industry focuses on the quality, not necessarily the quantity, of clients. This is because, for these Li-ion battery electrolyte manufacturers, gaining a quality client not only generates revenue, but also allows the company to learn from its client’s superior technical and R&D capabilities.

At present, Tinci’s client base is still mainly made up of domestic Chinese enterprises. However, if it succeeds in acquiring Dongguan Kaixin, Tinci will enter the supply chain of Amperex Technology Limited (ATL).

Not only is ATL the major supplier of Li-ion batteries for Apple Inc.’s digital products, it is also currently co-operating with BMW in a project to develop a power Li-ion battery for automobiles. In the future, ATL is widely expected to become BMW’s supplier for its alternative energy automobile business.  Entering the supply chain of such prestigious clients will surely help propel Tinci up the technology ladder, expand its business in both domestic and overseas markets, and possibly even allow it to seize the title of China’s leading Li-ion battery electrolyte supplier.

Tinci also plans to increase its production capacity of LiPF6 in the near future. According to a statement released by Tinci, the liquid LiPF6 project is designed mainly to deal with the rapid development in the alternative energy automobile industry and meet fast-growing downstream demand. The construction period for this liquid LiPF6 project is about 1.5 years and construction should be completed in 2016.

Once completed, the production capacity of this project will be 6,000t/a of liquid LiPF6, which is the equivalent of 2,000t/a of crystal LiPF6. This will double Tinci’s total capacity, which currently stands at 2,000 t/a of crystal LiPF6.

China’s LiPF6 market is currently suffering from overcapacity, but the rapid development of the alternative energy automobile industry is expected to drive up demand for Li-ion battery electrolyte. According to CCM, LiPF6 supply and demand in the LiPF6 market should balance out by 2015.

-          This article was provided by CCM, a leading provider of data and business intelligence on China’s chemicals market. CCM has launched China Li-ion Battery E-News, a new e-journal dedicated to analyzing all the latest news and trends in China’s Li-ion battery industry. For more information on CCM and China Li-ion Battery E-News, please visit www.cnchemicals.com or contact econtact@cnchemicals.com
-           
-          Facebook: https://www.facebook.com/ccmkate

-          Twitter: https://twitter.com/CCM_Kcomber

Tuesday, January 7, 2014

18 self-developed pesticides without renewal of technical registrations


ZJ0712 (Chinese name: Benmijunzhi)
 
ZJ0712, namely E-2[2-(2,5-dimethyl-phenoxy)-phenylmethyl]-3-methoxy-acrylic acid methyl ester, was jointly developed by Zhejiang Chem-Tech Group Co., Ltd. (Former name: Zhejiang Chemical Industry Research Institute, ZCIRI for short) and Zhejiang Hetian Chemical Co., Ltd. (Zhejiang Hetian) during the 9th Five-year plan period (1995-2000). ZJ0712 is a methoxyacrylate fungicide with excellent control effect on powdery mildew of wheat and apple, downy mildew of cucumber, grape and litchi, anthracnose of watermelon and mango, etc. It stimulates crop growth as well.
 
According to Mr. Lu, a sales manager from Zhejiang Hetian, the company had achieved Chinese invention patent (patent number: ZL 03120882.7) and World intention patent (WO2004084632) for ZJ0712. According to the ICAMA, Zhejiang Hetian had obtained temporary registration certificates for ZJ0712 technical (98%) and its 10% SC in 2008, but these two registrations both expired in Aug. 2011 without renewal.
 
Propamidine
 
Propamidine, an amidine fungicide with high control effects on downy mildew, phytophthora, anthracnose, etc. especially gray mold, was innovated and developed in 2004 by Zhang Xing, professor from Northwest A&F University.
 
Professor Zhang cooperated with Shaanxi Yangling Pesticide Chemical Industry Co., Ltd. (Yangling Pesticide) to realize propamidine commercialization in 2004. Two temporary registrations have been obtained, for propamidine technical (No: LS20040092) and 2% AS (No. LS20040130) respectively. However, the temporary registrations were not extended due to the limited promotion of the product in the market, as Yangling Pesticide doesn't have wide sales channels and sufficient capital for its promotion. Now Professor Zhang is seeking for other cooperators. Except for propamidine, Professor Zhang also developed a series of propamidine derivatives which were claimed to be great market potential as fungicides.
 
Ascomycin (SPRI-2098)
 
Ascomycin, a novel low residue bio-fungicide developed by Shanghai Pesticide Research Institute (SPRI), is highly effective for the control of botrytis cinerea on various crops, such as tomato, cucumber, strawberry, eggplant and summer squash.
 
In Aug. 2004, a company named Shanghai Nanshen Science & Technology Development Co., Ltd. registered ascomycin technical (94%) and its 1% EC, according to the ICAMA. In 2007, the company didn't get the renewal for these registrations any more.
 
Subsequently, SPRI transferred the property right of ascomycin to Zhejiang Hisun Chemical Co., Ltd. (Zhejiang Hisun). Then, Zhejiang Hisun obtained two registration certificates of ascomycin (also 94% technical and 1% EC) in Dec. 2007 and Mar. 2009 respectively. Whereas, it was frustrated that Zhejiang Hisun gave up the registration renewal in 2010 and 2011 respectively.

ZJ0712 (Chinese name: Benmijunzhi)
 
ZJ0712, namely E-2[2-(2,5-dimethyl-phenoxy)-phenylmethyl]-3-methoxy-acrylic acid methyl ester, was jointly developed by Zhejiang Chem-Tech Group Co., Ltd. (Former name: Zhejiang Chemical Industry Research Institute, ZCIRI for short) and Zhejiang Hetian Chemical Co., Ltd. (Zhejiang Hetian) during the 9th Five-year plan period (1995-2000). ZJ0712 is a methoxyacrylate fungicide with excellent control effect on powdery mildew of wheat and apple, downy mildew of cucumber, grape and litchi, anthracnose of watermelon and mango, etc. It stimulates crop growth as well.
 
According to Mr. Lu, a sales manager from Zhejiang Hetian, the company had achieved Chinese invention patent (patent number: ZL 03120882.7) and World intention patent (WO2004084632) for ZJ0712. According to the ICAMA, Zhejiang Hetian had obtained temporary registration certificates for ZJ0712 technical (98%) and its 10% SC in 2008, but these two registrations both expired in Aug. 2011 without renewal.
 
Propamidine
 
Propamidine, an amidine fungicide with high control effects on downy mildew, phytophthora, anthracnose, etc. especially gray mold, was innovated and developed in 2004 by Zhang Xing, professor from Northwest A&F University.
 
Professor Zhang cooperated with Shaanxi Yangling Pesticide Chemical Industry Co., Ltd. (Yangling Pesticide) to realize propamidine commercialization in 2004. Two temporary registrations have been obtained, for propamidine technical (No: LS20040092) and 2% AS (No. LS20040130) respectively. However, the temporary registrations were not extended due to the limited promotion of the product in the market, as Yangling Pesticide doesn't have wide sales channels and sufficient capital for its promotion. Now Professor Zhang is seeking for other cooperators. Except for propamidine, Professor Zhang also developed a series of propamidine derivatives which were claimed to be great market potential as fungicides.
 
Ascomycin (SPRI-2098)
 
Ascomycin, a novel low residue bio-fungicide developed by Shanghai Pesticide Research Institute (SPRI), is highly effective for the control of botrytis cinerea on various crops, such as tomato, cucumber, strawberry, eggplant and summer squash.
 
In Aug. 2004, a company named Shanghai Nanshen Science & Technology Development Co., Ltd. registered ascomycin technical (94%) and its 1% EC, according to the ICAMA. In 2007, the company didn't get the renewal for these registrations any more.
 
Subsequently, SPRI transferred the property right of ascomycin to Zhejiang Hisun Chemical Co., Ltd. (Zhejiang Hisun). Then, Zhejiang Hisun obtained two registration certificates of ascomycin (also 94% technical and 1% EC) in Dec. 2007 and Mar. 2009 respectively. Whereas, it was frustrated that Zhejiang Hisun gave up the registration renewal in 2010 and 2011 respectively.

ZJ0712 (Chinese name: Benmijunzhi)
 
ZJ0712, namely E-2[2-(2,5-dimethyl-phenoxy)-phenylmethyl]-3-methoxy-acrylic acid methyl ester, was jointly developed by Zhejiang Chem-Tech Group Co., Ltd. (Former name: Zhejiang Chemical Industry Research Institute, ZCIRI for short) and Zhejiang Hetian Chemical Co., Ltd. (Zhejiang Hetian) during the 9th Five-year plan period (1995-2000). ZJ0712 is a methoxyacrylate fungicide with excellent control effect on powdery mildew of wheat and apple, downy mildew of cucumber, grape and litchi, anthracnose of watermelon and mango, etc. It stimulates crop growth as well.
 
According to Mr. Lu, a sales manager from Zhejiang Hetian, the company had achieved Chinese invention patent (patent number: ZL 03120882.7) and World intention patent (WO2004084632) for ZJ0712. According to the ICAMA, Zhejiang Hetian had obtained temporary registration certificates for ZJ0712 technical (98%) and its 10% SC in 2008, but these two registrations both expired in Aug. 2011 without renewal.
 
Propamidine
 
Propamidine, an amidine fungicide with high control effects on downy mildew, phytophthora, anthracnose, etc. especially gray mold, was innovated and developed in 2004 by Zhang Xing, professor from Northwest A&F University.
 
Professor Zhang cooperated with Shaanxi Yangling Pesticide Chemical Industry Co., Ltd. (Yangling Pesticide) to realize propamidine commercialization in 2004. Two temporary registrations have been obtained, for propamidine technical (No: LS20040092) and 2% AS (No. LS20040130) respectively. However, the temporary registrations were not extended due to the limited promotion of the product in the market, as Yangling Pesticide doesn't have wide sales channels and sufficient capital for its promotion. Now Professor Zhang is seeking for other cooperators. Except for propamidine, Professor Zhang also developed a series of propamidine derivatives which were claimed to be great market potential as fungicides.
 
Ascomycin (SPRI-2098)
 
Ascomycin, a novel low residue bio-fungicide developed by Shanghai Pesticide Research Institute (SPRI), is highly effective for the control of botrytis cinerea on various crops, such as tomato, cucumber, strawberry, eggplant and summer squash.
 
In Aug. 2004, a company named Shanghai Nanshen Science & Technology Development Co., Ltd. registered ascomycin technical (94%) and its 1% EC, according to the ICAMA. In 2007, the company didn't get the renewal for these registrations any more.
 
Subsequently, SPRI transferred the property right of ascomycin to Zhejiang Hisun Chemical Co., Ltd. (Zhejiang Hisun). Then, Zhejiang Hisun obtained two registration certificates of ascomycin (also 94% technical and 1% EC) in Dec. 2007 and Mar. 2009 respectively. Whereas, it was frustrated that Zhejiang Hisun gave up the registration renewal in 2010 and 2011 respectively.

Pyribambenz-propyl (ZJ0273) and pyribambenz-isopropyl (ZJ0702)
 
Both belonging to miazines herbicides, pyribambenz-propyl and pyribambenz-isopropyl which could control annual grassy weeds and some broadleaf weeds in rape field were jointly developed by ZCIRI and Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences. Although Shandong Qiaochang acquired temporary registrations of both two herbicides in 2003, both have already expired.
 
Methiopyrsulfuron (HNPC-C9908)
 
Methiopyrsulfuron is a sulfonylurea herbicide developed by HRICI. HRICI was cooperating with a company in methiopyrsulfuron commercialization. Hunan Haili registered 95% methiopyrsulfuron technical (Reg.  No.:LS20060244) and methiopyrsulfuron 10% WP (Reg. No.:LS20060229) in 2006, which both expired. The latter was registered for post-emergence control of broad-leaf weeds and some grassy weeds in wheat fields. Methiopyrsulfuron got patent in China in 2003 (Patent Number: ZL00113423.X).
 
Clacyfos (HW02)
 
Clacyfos, developed by the Central China Normal University in 2009 under the code name of HW02, is a phosphonate ester of the phenoxyacetic herbicide. As a herbicide with independent intellectual property rights, clacyfos owns a very good capacity in managing annual broadleaf weeds and some monocotyledonous weeds in the field of corn, wheat and lawn, orchard and tea garden, such as amaranthus retroflexus, acalypha and abutilon. The mechanism of action of clacyfos is the inhibitor of pyruvate dehydrogenase. Shandong Qiaochang secured the temporary registrations of clacyfos (93% technical and 30% EC) in 2007.


China Crop Protection Monthly Report, a monthly publication issued by CCM, will keep an eye on the most important or the latest occurrences or the hottest topics in China’s crop protection industry, and select one or two topics out of these news and information to compose an in-depth feature article. You can obtain professional and insightful intelligence, covering market dynamic, industry development, government policies and more by going through the features articles every month.

About CCM
CCM is dedicated to market research in China, Asia-Pacific Rim and global market. With a staff of more than 150 dedicated highly-educated professionals, CCM offers Market Data, Analysis, Reports, Newsletters, Buyer-Trader Information, Import/Export Analysis, and Consultancy Service. 

For more information, please visit http://www.cnchemicals.com.

Guangzhou CCM Information Science & Technology Co., Ltd.
17th Floor, Huihua Commercial & Trade Mansion, No.80 Xianlie Zhong Road, Guangzhou 510070, China
Tel: 86-20-37616606

Thursday, October 10, 2013

Two domestic erythritol producers have contradicting erythritol sales performance in H1 2013

According to CCM’s latest newsletter, Sweeteners China News 1310, Two Chinese erythritol producers, namely Baolingbao Biology Co., Ltd. (Baolingbao, whose production capacity of erythritol is 4,000t/a in China) and Shandong Binzhou Sanyuan Biotechnology Co., Ltd. (Binzhou Sanyuan, production capacity of erythritol is 5,000t/a in 2013), showed contradicting performance in erythritol sales in H1 2013. It is worth mentioning that Baolingbao is a leading functional sugar producer in China having several functional sugar products, while the erythritol business of Binzhou Sanyuan's contributed the total revenue for the company.

Data from the 2013 semi-annual report of Baolingbao revealed that its erythritol business performed poorly in H1 2013. The gross profit of Baolingbao's erythritol reached as high as USD0.81 million in H1 2012, but it decreased by 71% YoY to USD0.23 million in H1 2013. Baolingbao expressed that the poor performance of its erythritol was mainly attributed to the negative effect of the RMB appreciation and the demand decrease from several foreign countries. The appreciation of RMB caused the lower RMB export price (relative to the fixed dollar price for erythritol), reducing the gross profit margin. The gross profit margin of the company's sugar alcohol business decreased to 7.66% in H1 2013 from 15.87% in H1 2012. Besides, Baolingbao also indicated that some political factors caused decreases in its export volume. For example, the export volume to Japan and Philippines decreased in H1 2013 compared to H1 2012, due to the political disputes between China and these two countries.

Baolingbao could not explain well the poorer sales performance of its erythritol in comparison to that of Binzhou Sanyuan's. According to the 2013 semi-annual report of Binzhou Sanyuan, the revenue of the company's erythritol increased to USD1.37 million in H1 2013, with a YoY up of 36.10%. Binzhou Sanyuan was honest to express that the RMB appreciation also brought negative effects on its product's export price in H1 2013 but the company focused on cost reduction and product quality. For example, the company actively established a cooperation with the well known Chinese research institutions to improve its R&D ability and hence its revenue growth. The year-on-year increase rate of erythritol's cost of sales in H1 2013 was just 16.93%, far lower than the one of its revenue at the same time. And the gross profit margin of erythritol of Binzhou Sanyuan also increased to 17.89% in H1 2013.

It is crucial that Baolingbao invest in the R&D in line with Binzhou Sanyuan. As a producer exclusively engaging in the production of erythritol, Binzhou Sanyuan devotes its energy to the research and sales of its erythritol. On the contrary, due to its diverse product range, Baolingbao cannot focus entirely on erythritol's sales. As a result, under the adverse conditions such as the RMB appreciation in H1 2013, Binzhou Sanyuan could depend on product's high quality to attract more downstream customers from overseas market, enjoying more profit compared to the same period of 2012.
 
For domestic erythritol producers, the objective conditions are the same. Subjective factors, such as more investment in quality improvement and market exploration, will become the determinants to obtain good performance, especially under the bad objective conditions. As an export-oriented industry, the export volume of China's erythritol decreased sharply, from over 2,800 tonnes in the first five months of 2012 to just about 1,900 tonnes in the same period of 2013. Under the negative export conditions, domestic erythritol producers should have a positive attitude to solve their problems.

Table of Contents of Sweeteners China News 1310:
H1 2013 still tough for domestic crystalline glucose industry
Starch sugar producers selling more corn starch threatens domestic corn starch industry
Functional oligosaccharide business of three oligosaccharide giants: challenges hidden behind good performance
Two domestic erythritol producers have contradicting erythritol sales performance in H1 2013
Guilin Layn turns loss into gain in H1 2013
PureCircle: sales performance good while suffering continous losses in FY2013
Export overview of some sweeteners and raw materials in China, August 2013
YoY growth rate of export volume of China's sucralose drops sharply in H1 2013
China's aspartame export not as optimistic as it showed under independent HS code
China's mannitol export: both volume and price increase in Jan. -Aug. 2013
International and domestic factors together impact China's sucrose price in Q4 2013
Ex-factory prices of sweeteners in China in September 2013
Wanfu Biotechnology continues to suffer losses in H1 2013
Zhaoqing Coruscate's starch syrup project starts to build in Sept. 2013
Guangxi government introduces policies to promote health development of its sucrose industry

Sweeteners China News, issued by CCM on 5th every month, offers timely update and close follow-up of market and company dynamics based on China’s sweeteners industry. It also releases the latest information on raw material supply, price update, import & export analysis as well as consumption trend & competitiveness.

CCM is dedicated to market research in China, Asia-Pacific Rim and global market. With a staff of more than 150 dedicated highly-educated professionals, CCM offers Market Data, Analysis, Reports, Newsletters, Buyer-Trader Information, Import/Export Analysis, and Consultancy Service. 

For more information, please visit http://www.cnchemicals.com.

Guangzhou CCM Information Science & Technology Co., Ltd.
17th Floor, Huihua Commercial & Trade Mansion, No.80 Xianlie Zhong Road, Guangzhou 510070, China
Tel: 86-20-37616606

Email: econtact@cnchemicals.com